These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 12966490)

  • 21. Docetaxel chemotherapy induces transverse superficial loss of the nail plate.
    Llombart-Cussac A; Pivot X; Spielmann M
    Arch Dermatol; 1997 Nov; 133(11):1466-7. PubMed ID: 9371043
    [No Abstract]   [Full Text] [Related]  

  • 22. [Yellow nails].
    Auvinet M; Dahan S; Dingremont C; Ollier S; Juchet H; Arlet P
    Rev Med Interne; 1998 May; 19(5):353-4. PubMed ID: 9775172
    [No Abstract]   [Full Text] [Related]  

  • 23. Docetaxel and epirubicin plus G-CSF mobilize hematopoietic progenitors in breast cancer.
    Pierelli L; Leone G; Cortesi E; Martelli O; Perillo A; Mancuso S; Scambia G
    Ann Oncol; 1999 Dec; 10(12):1531-2. PubMed ID: 10643552
    [No Abstract]   [Full Text] [Related]  

  • 24. Docetaxel as neoadjuvant chemotherapy in patients with stage III breast cancer.
    Gradishar WJ
    Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):15-8. PubMed ID: 9364536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Fulminant hepatocellular necrosis following administration of docetaxel].
    Tomassini E; Muhizi J; al Raheb K; Steinbach G; Bemer M; Platini C
    Presse Med; 2001 Apr; 30(13):634. PubMed ID: 11346902
    [No Abstract]   [Full Text] [Related]  

  • 26. Is weekly docetaxel an active and gentle chemotherapy in the treatment of metastatic breast cancer?
    Maisano R; Mare M; Zavettieri M; Caristi N; Mesiti M; Scisca C; La Torre F
    Anticancer Res; 2003; 23(2C):1923-6. PubMed ID: 12820480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The development of docetaxel (Taxotere) in non-small cell lung cancer.
    Kris MG; Miller VA; Ng KK; Grant SC
    Semin Oncol; 1997 Aug; 24(4 Suppl 14):S14-1-S14-4. PubMed ID: 9335515
    [No Abstract]   [Full Text] [Related]  

  • 28. Colitis associated with docetaxel-based chemotherapy in patients with metastatic breast cancer.
    Ibrahim NK; Sahin AA; Dubrow RA; Lynch PM; Boehnke-Michaud L; Valero V; Buzdar AU; Hortobagyi GN
    Lancet; 2000 Jan; 355(9200):281-3. PubMed ID: 10675076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Docetaxel (Taxotere) for advanced breast cancer.
    Med Lett Drugs Ther; 1996 Sep; 38(984):87-8. PubMed ID: 8828520
    [No Abstract]   [Full Text] [Related]  

  • 30. Risks and benefits of taxanes in breast and ovarian cancer.
    Michaud LB; Valero V; Hortobagyi G
    Drug Saf; 2000 Nov; 23(5):401-28. PubMed ID: 11085347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Review of recent trials of chemotherapy for advanced breast cancer: the taxanes.
    Clemons M; Leahy M; Valle J; Jayson G; Ranson M; Howell A
    Eur J Cancer; 1997 Nov; 33(13):2183-93. PubMed ID: 9470804
    [No Abstract]   [Full Text] [Related]  

  • 32. Combination docetaxel/cyclophosphamide in patients with advanced solid tumors.
    Valero V
    Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):34-6. PubMed ID: 9364540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Review of docetaxel/doxorubicin combination in metastatic breast cancer.
    Diéras V
    Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):31-3. PubMed ID: 9364539
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paclitaxel and docetaxel. Innovation, but at what cost?
    Lønning PE
    Pharmacoeconomics; 1995 Jul; 8(1):1-4. PubMed ID: 10155597
    [No Abstract]   [Full Text] [Related]  

  • 35. Docetaxel/doxorubicin/cyclophosphamide in the treatment of metastatic breast cancer.
    Nabholtz JM; Smylie M; Mackey JR; Noel D; Paterson AH; al-Tweigeri T; Au D; Sansregret E; Delorme F; Riva A
    Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):37-41. PubMed ID: 9364541
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypertrophic osteoarthropathy associated with docetaxel treatment.
    Tas F; Aydiner A; Tenekeci N; Karadeniz A; Sakar B; Topuz E
    Clin Oncol (R Coll Radiol); 2001; 13(2):145-6. PubMed ID: 11373880
    [No Abstract]   [Full Text] [Related]  

  • 37. Docetaxel: today's results and tomorrow's promises.
    Hortobagyi GN
    Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):11-4. PubMed ID: 9364535
    [No Abstract]   [Full Text] [Related]  

  • 38. [Docetaxel symposium].
    Viens P
    Bull Cancer; 1997 Aug; 84(8):833-4. PubMed ID: 9339190
    [No Abstract]   [Full Text] [Related]  

  • 39. Bevacizumab and osteonecrosis of the jaw: incidence and association with bisphosphonate therapy in three large prospective trials in advanced breast cancer.
    Guarneri V; Miles D; Robert N; Diéras V; Glaspy J; Smith I; Thomssen C; Biganzoli L; Taran T; Conte P
    Breast Cancer Res Treat; 2010 Jul; 122(1):181-8. PubMed ID: 20361252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Response to dexamethasone in patients with fluid retention after docetaxel.
    Chan S; Winterbottom L; Gardner S
    Lancet; 1996 May; 347(9013):1486-7. PubMed ID: 8676655
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.